» Articles » PMID: 16183497

Polymerized Hemoglobin Induces Heme Oxygenase-1 Protein Expression and Inhibits Intercellular Adhesion Molecule-1 Protein Expression in Human Lung Microvascular Endothelial Cells

Overview
Journal J Am Coll Surg
Date 2005 Sep 27
PMID 16183497
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Our clinical trials using a polymerized hemoglobin solution (PolyHb) as a red cell substitute in severely injured patients suggested that this hemoglobin-based oxygen carrier has a systemic antiinflammatory effect. Heme oxygenase-1 (HO-1) has recently been shown to be cytoprotective, and is known to be induced by heme moieties. We investigated the effects of this hemoglobin-based oxygen carrier on HO-1 induction and proinflammatory activation of pulmonary endothelium.

Study Design: Human lung microvascular endothelial cells were grown to confluence and preincubated with either cell media (control) or with an equal volume mixture of polymerized hemoglobin/cell media (experimental). The cell cultures were subsequently stimulated with lipopolysaccharide. HO-1 expression was detected by protein immunoblot and further quantified by ELISA; intercellular adhesion molecule-1 protein expression was measured by flow cytometry.

Results: Polymerized hemoglobin induced synthesis of HO-1 protein in human lung microvascular endothelial cells and, concurrently, inhibited lipopolysaccharide-induced intercellular adhesion molecule-1 protein cell surface expression.

Conclusions: Polymerized hemoglobin attenuates lipopolysaccharide-stimulated expression of intercellular adhesion molecule-1 protein, which is associated with upregulation of the cytoprotective protein HO-1 in human pulmonary endothelial cells. This antiinflammatory effect offers a novel mechanism by which hemoglobin-based oxygen carrier solutions may be exploited therapeutically as resuscitative fluids.

Citing Articles

Oxygen carriers affect kidney immunogenicity during machine perfusion.

Rother T, Horgby C, Schmalkuche K, Burgmann J, Nocke F, Jagers J Front Transplant. 2024; 2:1183908.

PMID: 38993849 PMC: 11235266. DOI: 10.3389/frtra.2023.1183908.